(Q39869071)

15 September 2017

title

Adjuvant engineering for cancer immunotherapy: Development of a synthetic TLR2 ligand with increased cell adhesion (English)

1 reference

15 September 2017

0 references

1 reference

1 reference

Takashi Akazawa

1

1 reference

15 September 2017

Norimitsu Inoue

2

1 reference

15 September 2017

Hiroaki Shime

3

1 reference

15 September 2017

Ken Kodama

4

1 reference

15 September 2017

Misako Matsumoto

5

1 reference

15 September 2017

Tsukasa Seya

6

1 reference

15 September 2017

language of work or name

1 reference

5 April 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

101

1 reference

15 September 2017

issue

7

1 reference

15 September 2017

page(s)

1596-1603

1 reference

Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01583.X

Dendritic cell maturation induced by muramyl dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01583.X

Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01583.X

Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01583.X

Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01583.X

10.1111/J.1349-7006.2010.01583.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference